Growth Stock Wire Investment Newsletter

 
Growth Stock Wire Investment Newsletter About Growth Stock Wire Frequently Asked Questions Growth Stock Wire Archives Contact Us Privacy Policy
Print Edition | Sponsored Link:

Where to Find the Best Hidden Health Care Investments
By Rob Fannon, editor, The Medical Investor
March 16, 2007

It's no secret that Americans spend a fortune on health care… about 16 cents of every dollar made, in fact.

Last year alone, we spent $2.1 trillion on medical expenses.

So, where does all of this money go? Well, as you can imagine, a lot goes to doctors, hospitals, and drug and insurance companies. That's no surprise.

But there is a handful of little-known medical businesses you've probably never heard of, some of which make an absolute fortune for shareholders, year after year.

Contract research organizations (CROs), for example, handle the nitty-gritty of drug trials for Big Pharma. Last year, drugmakers spent $60 billion on research, funneling of 25% to CROs. That number is expected to double in five years' time.

Another out-of-the-way industry, medical devices, sells premium-priced, high-margin products and generates big cash flows. As baby boomers head into an active retirement and as America's waistline expands, medical devices – like drug-coated heart stents, pacemakers, and joint replacements – are going to be more and more in demand.

Actually, the health care industry is hiding a few more of these gems...

  • Pharmacy benefit managers (PBMs) are third-party vendors that organize and operate prescription-drug benefits for private employers. For example, a PBM might develop a list of drugs available to employees and negotiate bulk-sales contracts with drug companies on its client's behalf. Of course, in the process, PBMs rake in tons of money.
  • The insurance industry is highly fragmented, opaque, and downright messy. Medicaid-only insurance companies, however, make up a highly profitable niche, focusing exclusively on managing government-sponsored medical insurance benefits.
  • Drug wholesalers essentially act as middlemen, getting prescription drugs from the point of manufacturing to the patients that need to take them. In my next essay, I'll discuss a company that gets paid every time a drug is dispensed in America's nursing homes.

American consumers are pouring money into the health care sector (remember, we spent $2.1 trillion last year). And with the market's recent volatility, investors are flocking to "defensive" sectors, like health care.

The average investor will do well putting money into the obvious health care plays, companies you might read about in the Wall Street Journal. But superior returns can be found in these behind-the-scene players.

Stay tuned next week for more details...

Good investing,

Rob Fannon

Thai Oil is Cheap
Crude oil costs the same all over Asia. Oil refiners don't, especially in Thailand.

Investors value PTT Pcl, which owns stakes in most of the country's chemical makers and refiners, at nearly half the price-earnings ratio of the average Asian oil and gas stock. Thai Oil Pcl, the biggest refiner, sells for 30 percent less. Read on...

Wal-Mart Wants to Give Banking a Try
Wal-Mart Stores Inc., underscoring its continuing push into financial services, has quietly renegotiated the terms of leases with a number of banks operating in its stores, giving Wal-Mart itself the explicit right to offer mortgages, home-equity lines of credit and consumer loans.

A portion of one of the leases, obtained by Dow Jones Newswires, also gives Wal-Mart the ability to offer debit cards and investment and insurance products either directly or through a third-party vendor.

In the wording of the new lease, Wal-Mart said it could "offer these products and services in the checkout lanes, at the customer-service desk, through automated-delivery channels, kiosks" or any other place in the store. WSJ ($) Read on...


Medical-device giants Stryker, Akzo Nobel, and Baxter all at 52-week highs

Oil pipeline companies continue to lead market: Martin Midstream, Valero LP, Magellan Midstream, Kinder Morgan Energy, and Martin Midstream hit new highs

In the news: Wal-Mart to sell loans at the checkout counter.

Last Change 52-Wk
S&P 500 1392.28 0.37% 6.85%
Oil (USO)* 48.67 -0.96% -28.26%
Gold (GLD) 63.98 0.06% 16.07%
Silver (SLV)* 129.31 1.02% -6.38%
US Dollar 83.64 -0.02% -6.88%
Euro 1.324 0.10% 9.82%
VIX 17.27 -4.74% 60.80%
HUI 320.56 0.58% 6.64%
10-year yield 4.52% 0.03 -0.17
* Since ETF inception

Advertisement

Company Sym Industry

BE Aerospace

BEAV

aerospace

Pep Boys

PBY

auto parts

Martin Midstream

MMLP

oil & gas pipeline

Akzo Nobel

AKZOY

medical equip

Valero LP

VLI

oil & gas pipeline

Cadbury Schweppes

CSG

food products

Big Lots

BIG

discount retailer

Magellan Midstream

MMP

oil & gas pipeline

Stryker

SYK

medical equip

Ascent Solar Tech

ASTI

solar power

Cambrex

CBM

biotech

Metal Management

MM

steel

Kinder Morgan Energy

KMP

oil & gas pipeline

Universal

UVV

tobacco products

Baxter

BAX

medical equip

Bon-Ton Stores

BONT

department store

Quilmes

LQU

beer

PNC Financial Srvcs

PNC

bank

Intl. Aluminum

IAL

aluminum

Holly Corp

HOC

oil

Enterprise Products

EPD

oil

Quanta Services

PWR

contracting

Unilever

UL

consumer prod

CBOT Holdings

BOT

derivative exch

Fairfax Financial Hold

FFH

insurance

Oneok

OKE

utilities

Phelps Dodge

PD

copper

Company Sym Industry

Orleans Homebuilders

OHB

homebuilder

Jefferson Bancshares

JFBI

holding company

W&T Offshore

WTI

oil drilling

Mitsubishi UFJ

MTU

bank

Home | About GSW | FAQ | GSW Archive | Privacy Policy | Contact Us

Customer Service: 1-888-261-2693 – Copyright 2010 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202